X4 Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $8,806 | $2,708 | $2,568 | $1,765 |
Gross Profit | 7,189 | 2,110 | 2,181 | 1,391 |
EBITDA | -12,771 | -17,871 | -21,516 | -27,365 |
EBIT | -13,991 | -18,107 | -21,739 | -27,588 |
Net Income | -16,157 | -20,241 | -23,925 | -29,815 |
Net Change In Cash | 8,806 | 2,708 | 2,568 | 1,765 |
Free Cash Flow | -40,387 | -19,599 | -15,527 | -27,822 |
Cash | 195,095 | 216,908 | 217,049 | 69,632 |
Basic Shares | 126,344 | 126,288 | 110,556 | 43,272 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $35,113 | $2,557 | $0 | $0 |
Gross Profit | 28,856 | 1,760 | -1,996 | -1,994 |
EBITDA | -69,005 | -27,576 | -94,893 | -89,333 |
EBIT | -70,282 | -28,372 | -95,312 | -89,846 |
Net Income | -79,199 | -37,450 | -101,167 | -93,867 |
Net Change In Cash | 35,113 | 2,557 | 0 | 0 |
Cost of Revenue | 40,025 | |||
Free Cash Flow | -88,618 | -138,227 | -96,572 | -77,205 |
Cash | 217,049 | 55,699 | 99,216 | 121,718 |
Basic Shares | 42,292 | 6,702 | 5,927 | 2,117 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.13 |
2026-03-31 | -$0.16 |
2025-12-31 | -$0.22 |
2025-09-30 | -$0.69 |